Related Experiment Video
Updated: Jun 18, 2026

Quantitative Analysis of Climbing Defects in a Drosophila Model of Neurodegenerative Disorders
Published on: June 13, 2015
Trehalose improves the movement ability of AβarcDrosophila by restoring the damaged mitochondria
Liangxian Li1,2, Zhiheng Huang1,3, Mingli Wu2
1Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Guilin Medical University, Guilin, 541199, China.
Background:
The deposition of Aβ42 has been regarded as one of the important pathological features of Alzheimer's disease (AD). However, drug development for Aβ42 toxicity has been progressed slowly.
Objective:
Our aim was to introduce the effect and related mechanism of trehalose on an Aβarc (arctic mutant Aβ42) Drosophila AD model.
Methods:
The human Aβarc was expressed in Drosophila to construct the AD model. Trehalose was added to the culture vial. The movement ability was determined by detecting climbing ability and flight ability. Enzyme-linked immunosorbent assay was used to detect the levels of Aβarc, ATP, and lactate. Electron microscopy assay, mitochondrial membrane potential assay, and mitochondrial respiration assay were used to assess the mitochondrial structure and function.
Results:
Trehalose strongly improved the movement ability of Aβarc Drosophila in a concentration gradient-dependent manner. Furthermore, trehalose increased the content of ATP and decreased the content of Aβarc and lactate both in the brain and thorax of Aβarc Drosophila. More importantly, the mitochondrial structure and function were greatly improved by trehalose treatment in Aβarc Drosophila.
Conclusion:
Trehalose improves movement ability at least partly by reducing the Aβarc level and restoring the mitochondrial structure and function in Aβarc Drosophila.
Insights
Trehalose significantly enhances movement in a Alzheimer's disease (AD) fruit fly model by reducing amyloid-beta (Aβ) levels and restoring mitochondrial function. This study highlights trehalose as a potential therapeutic agent for AD.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Amyloid-beta (Aβ) deposition, particularly Aβ42, is a key hallmark of Alzheimer's disease (AD).
- Developing effective drugs targeting Aβ toxicity has faced significant challenges, necessitating novel therapeutic strategies.
Purpose of the Study:
- To investigate the therapeutic effects of trehalose on an Alzheimer's disease (AD) fruit fly model expressing arctic mutant Aβ42 (Aβarc).
- To elucidate the underlying mechanisms by which trehalose influences Aβ toxicity and associated pathologies.
Main Methods:
- Generation of a *Drosophila melanogaster* model expressing human Aβarc to mimic AD.
- Administration of trehalose and assessment of locomotor activity (climbing and flight).
- Biochemical analysis of Aβarc, ATP, and lactate levels; evaluation of mitochondrial structure and function using electron microscopy and functional assays.
Main Results:
- Trehalose treatment dose-dependently improved the movement ability of Aβarc fruit flies.
- Trehalose reduced Aβarc and lactate levels while increasing ATP content in both the brain and thorax.
- Significant restoration of mitochondrial structure and function was observed in trehalose-treated Aβarc flies.
Conclusions:
- Trehalose ameliorates AD-like phenotypes in a *Drosophila* model by reducing Aβarc levels.
- Trehalose restores mitochondrial structure and function, contributing to improved motor performance.
- These findings suggest trehalose holds promise as a therapeutic intervention for Alzheimer's disease.
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Export of Misfolded Proteins out of the ER

